Losing too much muscle while taking a GLP-1 medication can result in decreased strength, slower metabolism, increased risk of falls, and a higher likelihood of regaining weight once you stop taking the medication
This incremental approach mirrors evidence from clinical trials where gradual escalation produced better adherence and fewer side effects compared to faster titration schedules
Research might focus on prevention, early intervention, or application to other diseases like heart disease
To view a copy of this licence, visit About this article Cite this article de Rezende, V.L., Ebs, M.F.P., Daros, F
Continuous plan (2-3 months): Contributes to reducing fluid retention and alleviating tired legs
Altogether, these touches convert curiosity into longterm satisfaction